Regulation of mitotic spindle formation by the RhoA guanine nucleotide exchange factor ARHGEF10 by Aoki, Takuji et al.
BioMed  Central
Page 1 of 16
(page number not for citation purposes)
BMC Cell Biology
Open Access Research article
Regulation of mitotic spindle formation by the RhoA guanine 
nucleotide exchange factor ARHGEF10
Takuji Aoki, Shuji Ueda, Tohru Kataoka and Takaya Satoh*
Address: Division of Molecular Biology, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-
1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
Email: Takuji Aoki - takuaoki@med.kobe-u.ac.jp; Shuji Ueda - uedas@people.kobe-u.ac.jp; Tohru Kataoka - kataoka@people.kobe-u.ac.jp; 
Takaya Satoh* - tkysato@med.kobe-u.ac.jp
* Corresponding author    
Abstract
Background:  The Dbl family guanine nucleotide exchange factor ARHGEF10 was originally
identified as the product of the gene associated with slowed nerve-conduction velocities of
peripheral nerves. However, the function of ARHGEF10 in mammalian cells is totally unknown at
a molecular level. ARHGEF10 contains no distinctive functional domains except for tandem Dbl
homology-pleckstrin homology and putative transmembrane domains.
Results: Here we show that RhoA is a substrate for ARHGEF10. In both G1/S and M phases,
ARHGEF10 was localized in the centrosome in adenocarcinoma HeLa cells. Furthermore, RNA
interference-based knockdown of ARHGEF10 resulted in multipolar spindle formation in M phase.
Each spindle pole seems to contain a centrosome consisting of two centrioles and the
pericentriolar material. Downregulation of RhoA elicited similar phenotypes, and aberrant mitotic
spindle formation following ARHGEF10 knockdown was rescued by ectopic expression of
constitutively activated RhoA. Multinucleated cells were not increased upon ARHGEF10
knockdown in contrast to treatment with Y-27632, a specific pharmacological inhibitor for the
RhoA effector kinase ROCK, which induced not only multipolar spindle formation, but also
multinucleation. Therefore, unregulated centrosome duplication rather than aberration in
cytokinesis may be responsible for ARHGEF10 knockdown-dependent multipolar spindle
formation. We further isolated the kinesin-like motor protein KIF3B as a binding partner of
ARHGEF10. Knockdown of KIF3B again caused multipolar spindle phenotypes. The supernumerary
centrosome phenotype was also observed in S phase-arrested osteosarcoma U2OS cells when the
expression of ARHGEF10, RhoA or KIF3B was abrogated by RNA interference.
Conclusion: Collectively, our results suggest that a novel RhoA-dependent signaling pathway
under the control of ARHGEF10 has a pivotal role in the regulation of the cell division cycle. This
pathway is not involved in the regulation of cytokinesis, but instead may regulate centrosome
duplication. The kinesin-like motor protein KIF3B may modulate the ARHGEF10-RhoA pathway
through the binding to ARHGEF10.
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Background
Centrosomes coordinate the cytoplasmic microtubule
network serving as the major microtubule-organizing
centers in mammalian cells [1-3]. A single centrosome
consists of a pair of centrioles surrounded by the amor-
phous pericentriolar material (PCM). Centrioles are cylin-
drical structures built of nine sets of triplet microtubules,
and lie at right angles to each other and in close proximity
at one end. The PCM harbors a number of protein com-
plexes, including the γ-tubulin ring complex, which acts as
a template for microtubule nucleation. During M phase of
the cell cycle, two centrosomes orchestrate the assembly
of bipolar mitotic spindles, which is prerequisite for accu-
rate chromosome segregation. Aberrations in centrosome
numbers, which frequently occur in aggressive human
tumors, almost certainly represent one crucial cause of
missegregation of chromosomes, leading to a phenotype
termed genetic instability [3]. Therefore, the rigorous con-
trol of the duplication cycle of the centrosome is vital for
the cell. However, our understanding of the regulation of
the centrosome cycle remains incomplete.
The signal transducing GTPase RhoA has been implicated
in a variety of cellular responses in mammalian cells,
being regulated by Dbl family guanine nucleotide
exchange factors (GEFs) in a cell type- and signal-specific
manner [4]. Dbl Family GEFs contain Dbl homology
(DH) and pleckstrin homology (PH) domains in tandem,
which are responsible for enhancement of guanine nucle-
otide exchange on the target GTPase. The DH domain is a
catalytic domain whereas the PH domain is thought to be
required for the modulation of protein conformation and
subcellular localization [4]. A well characterized function
of RhoA is the regulation of cell division, particularly cyto-
kinesis [5,6]. Upon onset of anaphase, the GEF ECT2 acti-
vates RhoA, leading to the accumulation of activated
RhoA at the cleavage furrow. Activated RhoA in turn
directs assembly and contraction of the contractile ring
through the activation of various downstream effectors,
including formin family proteins, the Rho-dependent
kinase ROCK and citron kinase. Formin family proteins
regulate actin polymerization, allowing the formation of
the contractile ring. ROCK and citron kinase are involved
in the control of contractile ring ingression and comple-
tion of cytokinesis, respectively, through phosphorylation
of regulatory myosin light chains.
Increasing evidence has emerged that RhoA plays a pivotal
role not only in cytokinesis, but also in mitosis [6]. For
instance, ROCK regulates mother centriole movement in
late telophase and exit from mitosis [7]. During prophase/
prometaphase, RhoA and its GEF Lfc are required for the
assembly of the mitotic spindle [8]. Separation and posi-
tioning of duplicated centrosomes after nuclear envelope
breakdown, which are important for correct spindle align-
ment, may also be regulated by RhoA and ROCK [9].
The Dbl family GEF ARHGEF10 was originally identified
as the product of the gene associated with slowed nerve-
conduction velocities of peripheral nerves [10]. However,
underlying molecular mechanisms are totally unknown.
Also, the function of ARHGEF10 in mammalian cell cycle
progression remains to be clarified. ARHGEF10 was ini-
tially reported to possess a DH domain in its N-terminal
portion, but lack the PH domain [11]. Recently, however,
a less conserved PH domain in tandem with the DH
domain was identified [12] (see Figure 1A). C-terminally
located two transmembrane domains have also been pre-
dicted from amino acid sequence [11]. Based on the sim-
ilarity between human and mouse sequences, we
identified an additional putative transmembrane domain,
which lies immediately adjacent and C-terminal to the
original ones (Figure 1A). Except for the pair of DH and
PH domains and putative transmembrane domains, no
functional domain structures have been noted for
ARHGEF10. Herein, we investigate the role of ARHGEF10
in cell division control and demonstrate that ARHGEF10
regulates the centrosome number through the action on
its target RhoA.
Methods
Antibodies
Antibodies against Myc (mouse monoclonal [sc-40]),
FLAG (mouse monoclonal [F3165] and rabbit polyclonal
[F7425]) and hemagglutinin (HA) (rat monoclonal
[1867423]) epitope tags were purchased from Santa Cruz
Biotechnology, Sigma-Aldrich and Roche Applied Sci-
ence, respectively. An antibody against ARHGEF10
(mouse polyclonal [H00009639-B01]) was purchased
from Abnova. Antibodies against α-tubulin (mouse mon-
oclonal [T6199]), β-tubulin (mouse monoclonal
[T0198]), γ-tubulin (mouse monoclonal [T6557], rabbit
polyclonal [T3320]) and centrin (rabbit polyclonal
[C7736]) were purchased from Sigma-Aldrich. An anti-
body against pericentrin (rabbit polyclonal [PRB-432C])
was purchased from Covance. Antibodies against Aurora-
A (rabbit monoclonal [#4718]) and centrin-2 (rabbit
monoclonal [#2091]) were purchased from Cell Signaling
Technology. Anti-mouse IgG, anti-rabbit IgG and anti-rat
IgG antibodies conjugated with Alexa Fluor 488/546/647
were purchased from Invitrogen (Molecular Probes).
Plasmids, small interfering RNAs (siRNAs) and polymerase 
chain reaction (PCR) primers
cDNAs encoding HA × 3-tagged human small GTPases
(RhoA [wt], RhoA [G14V], Rac1 [G12V] and Cdc42
[G12V]) were subcloned into pEF-BOS for expression in
mammalian cells [13]. cDNAs encoding N-terminally
Myc-tagged full-length and truncated (amino acids 376–BMC Cell Biology 2009, 10:56 http://www.biomedcentral.com/1471-2121/10/56
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Figure 1 (see legend on next page)
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665 containing the DH domain) ARHGEF10 (also termed
KIAA0294, NCBI accession number NM_014629) were
subcloned into the mammalian expression vector pCMV5
(NCBI accession number AF239249). The cDNA encod-
ing N-terminally FLAG-tagged KIF3B (also termed
KIAA0359, NCBI accession number AB002357) was sub-
cloned into the mammalian expression vector pCMV5.
pCMV5-Myc-Dbl-I [14] and pFLAG-CMV2-EGFP [15]
were described previously. siRNAs for ARHGEF10 (Stealth
select HSS114404 [#1] and Stealth select HSS114405
[#2]), RhoA (Stealth select HSS100654 [#1], Stealth select
HSS100655 [#2] and Stealth select HSS100656 [#3]) and
KIF3B (Stealth select HSS113902 [#1], Stealth select
HSS113903 [#2] and Stealth select HSS113904 [#3]) were
purchased from Invitrogen. The control siRNA (Stealth
RNAi negative control medium GC duplex #3) was also
purchased from Invitrogen. Reverse transcriptase (RT)-
PCR was performed using specific primers (5'-caatatga-
gaagccgctgtc-3' and 5'-catattcacggtatgcatccag-3' for
ARHGEF10 [35 cycles], 5'-gatatcgaggtggatggaaag-3' and
5'-cacatcagtataacatcggtatc-3' for RhoA [32 cycles], 5'-
ggaaactacatcctataaccag-3' and 5'-cctgtatctcatcttcatcctg-3'
for KIF3B [35 cycles] and 5'-ccccttcattgacctcaactac-3' and
5'-atgaccttgcccacagccttgg-3' for glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) [35 cycles]) as described
[13].
Cell culture, transfection and synchronization
HeLa, COS7 and U2OS cells were cultivated in Dulbecco's
modified Eagle's Medium (Nacalai Tesque, Japan) supple-
mented with 10% (v/v) fetal bovine serum, 100 IU/ml
penicillin and 100 μg/ml streptomycin. For transfection,
SuperFect (Qiagen, for plasmids only), Lipofectamine
RNAiMAX (Invitrogen, for siRNAs only) and Lipo-
fectamine 2000 (Invitrogen, for a mixture of plasmids and
siRNAs) were used according to the manufacturer's
instructions (24 h-incubation with cells).
Synchronization of HeLa cells in M phase was achieved by
incubation of cells in 100 ng/ml nocodazole (Sigma-
Aldrich) for 20 h. Mitotic cells were collected by mitotic
shake-off, and released from the nocodazole block. If not
specified, cells were fixed, and subjected to immunofluo-
rescent staining after 90 min-incubation without nocoda-
zole. In some experiments, cells were pretreated with 50
μM Y-27632 (Calbiochem), which was also included dur-
ing nocodazole treatment.
Synchronization of HeLa cells in G1/S phase was achieved
by a double thymidine block. Cells were incubated in 10
mM thymidine (Sigma-Aldrich) for 24 h, and then
released from the first thymidine block for 10 h in the cul-
ture medium. A second block was initiated by adding 10
mM thymidine, and cells were maintained for 14 h. Cells
were then released from the thymidine block for the indi-
cated times.
Synchronization of U2OS cells in S phase was achieved by
incubation of cells in 1.6 μg/ml aphidicolin (Sigma-
Aldrich) for 16 h.
Immunofluorescent microscopy
Cells were fixed with cold methanol for 10 min, and
immunofluorescent staining was performed as previously
described [13-15] Images were obtained using a confocal
laser-scanning microscope (LSM 510 META; Carl Zeiss)
and processed by the Zeiss LSM Image Browser, version
3.5.
Substrate specificity and subcellular localization of ARHGEF10 Figure 1 (see previous page)
Substrate specificity and subcellular localization of ARHGEF10. (A) The domain structure of ARHGEF10. Amino acid 
residue numbers are shown. DH, Dbl homology; PH, pleckstrin homology. (B) GEF activity of ARHGEF10 toward RhoA. HA × 
3-tagged wild-type (wt) or constitutively activated (G14V) RhoA was expressed with Myc-tagged Dbl or Myc-tagged 
ARHGEF10(376–665) in COS7 cells. Levels of the GTP-bound form were measured by pull-down assays using GST-Dia(1–
304). Expression levels of RhoA and GEFs were determined by immunostaining with anti-tag antibodies. (C) Co-localization of 
ARHGEF10 and RhoA in centrosomes. HA × 3-tagged RhoA(wt) was expressed in HeLa cells, and indicated proteins were 
immunostained. Scale bar, 10 μm. (D) Subcellular localization of ARHGEF10 in unsynchronized cells. HeLa cells were cultivated 
in the growth medium, and indicated proteins were immunostained. Scale bar, 10 μm. (E) Subcellular localization of ARHGEF10 
in G1/S phase. HeLa cells were synchronized in G1/S phase with thymidine, and indicated proteins were immunostained. The 
high magnification image of the boxed area in the 3rd panel is shown in the 4th panel. Scale bar, 10 μm (1st-3rd panels) and 2 
μm (the 4th panel). Flow cytometric analysis of DNA content is also shown. (F) Subcellular localization of ARHGEF10 in M 
phase. HeLa cells were synchronized in M phase with nocodazole, and indicated proteins were immunostained. The high mag-
nification image of the boxed area in the 3rd panel is shown in the 4th panel. Scale bar, 10 μm (1st-3rd panels) and 2 μm (the 
4th panel). Flow cytometric analysis of DNA content is also shown. In (C) to (F), nuclei were stained with 4',6-diamidino-2-
phenylindole (DAPI), and arrowheads indicate centrosomes. Thin dotted lines in cell images in (C) to (F) indicate the contour 
of the cell.BMC Cell Biology 2009, 10:56 http://www.biomedcentral.com/1471-2121/10/56
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Figure 2 (see legend on next page)
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Pull-down assays
Pull-down assays for the activated form of RhoA was car-
ried out as described previously [13].
Immunoprecipitation and immunoblotting
COS7 cells were dissolved in lysis buffer (50 mM Tris-HCl
[pH 7.4], 150 mM NaCl, 20 mM MgCl2, 0.5% [v/v] Non-
idet P-40), and centrifuged at 20,000 × g for 10 min at
4°C. Cell lysates were incubated with protein G-Sepha-
rose beads and a specific antibody for 30 min at 4°C. Sub-
sequently, protein G-Sepharose beads were washed three
times with lysis buffer, and precipitated proteins were
subjected to SDS-PAGE and immunoblotting. Immunob-
lotting was performed as previously described[15].
Flow cytometric analysis of DNA content
Growing or synchronized HeLa cells were fixed with ice-
cold 70% [v/v] ethanol, and then resuspended in phos-
phate-buffered saline containing 20 μg/ml ribonuclease A
(Sigma). DNA was stained with 20 μg/ml propidium
iodide (Dojindo), and cytometric analysis was performed
on a flow cytometer (FACScan, Becton-Dickinson Immu-
nocytometry Systems). Collected data were processed by
CELLQuest.
Yeast two-hybrid screening
A MATCH MAKER yeast two-hybrid human brain library
(HY4004AH, Clontech, 5 × 106 independent clones) was
screened using an N-terminal region (amino acids 1–
1083) of ARHGEF10 as a bait according to the manufac-
turer's instructions. The interaction between isolated
clones and ARHGEF10(1–1083) was confirmed by
growth on the selection plate (synthetic dropout medium-
Trp/-Leu/-His/-Ade/+2.5 mM 3-aminotriazole) and the β-
galactosidase assay according to the manufacturer's
instructions.
Results
Involvement of ARHGEF10 in the regulation of mitotic 
spindle formation
As a first step to clarify the function of ARHGEF10 at a
molecular level, we attempted to identify substrate Rho
family GTPases for putative GEF activity of ARHGEF10 by
a pull-down assay (Figure 1B). In this assay, the activated
form of the GTPase accumulated within the cell was pre-
cipitated by a probe that selectively recognizes the active
form, and visualized by immunoblotting. When co-
expressed with a fragment of ARHGEF10 that contains cat-
alytic DH and regulatory PH domains, the activated form
of ectopically expressed wild-type RhoA was increased,
indicating that ARHGEF10 actually showed GEF activity
toward RhoA. GEF activity of ARHGEF10 was comparable
to that of Dbl, a previously characterized GEF for RhoA. In
contrast, GTP loading to Rac1 and Cdc42 was not
enhanced by ARHGEF10 as previously described [[12]
and data not shown]. Although a previous study demon-
strated GEF activity of ARHGEF10 toward RhoB, we were
unable to detect significant GEF activity toward RhoB
[[12] and data not shown]. When ectopically expressed in
HeLa cells, a subset of RhoA was indeed co-localized with
ARHGEF10 in centrosomes (Figure 1C) (see below).
Subcellular localization of ARHGEF10 was then deter-
mined by immunofluorescent staining (Figures 1D–1F).
Of note, ARHGEF10 was localized, at least in part, in cen-
trosomes visualized by counter staining of γ-tubulin in
unsynchronized HeLa cells in various phases of the cell
cycle (Figure 1D). Such centrosomal localization of
Multipolar spindle formation in ARHGEF10-knockdown HeLa cells Figure 2 (see previous page)
Multipolar spindle formation in ARHGEF10-knockdown HeLa cells. (A) Effect of ARHGEF10 siRNAs on mRNA 
expression. Expression levels of endogenous ARHGEF10 and GAPDH (control) mRNAs in HeLa cells transfected with indi-
cated siRNAs were measured by RT-PCR. (B) Effect of ARHGEF10 siRNA #1 on protein expression. Expression levels of Myc-
tagged ARHGEF10 and α-tubulin (control) in HeLa cells transfected with indicated siRNAs were measured by immunoblotting. 
M, molecular weight markers. (C) Subcellular localization of ARHGEF10 in M phase. HeLa cells were transfected with 
ARHGEF10 siRNA #1 or control siRNA and synchronized in M phase with nocodazole. Indicated proteins were immunos-
tained. Scale bar, 10 μm. (D) Immunostaining of centrin and γ-tubulin in ARHGEF10-knockdown cells. HeLa cells were trans-
fected with ARHGEF10 siRNA #1 and synchronized in M phase with nocodazole. Indicated proteins were immunostained. 
High magnification images of boxed areas are shown in lower panels. Scale bar, 10 μm (upper panels) and 1 μm (lower panels). 
(E) Immunostaining of α-tubulin and γ-tubulin in ARHGEF10-knockdown cells. Indicated proteins in HeLa cells treated as in (D) 
were immunostained. Scale bar, 10 μm. (F) Immunostaining of α-tubulin and pericentrin in ARHGEF10-knockdown cells. Indi-
cated proteins in HeLa cells treated as in (D) were immunostained. Scale bar, 10 μm. (G) Immunostaining of α-tubulin and 
Aurora-A in ARHGEF10-knockdown cells. Indicated proteins in HeLa cells treated as in (D) were immunostained. Scale bar, 10 
μm. (H) Quantification of multipolar spindle formation in ARHGEF10-knockdown cells. HeLa cells were transfected with indi-
cated siRNAs and synchronized in M phase with nocodazole. The percentage of cells containing multiple centrosomes are 
shown as the means ± S.E. for three independent experiments. *, P < 0.01. In (C) to (G), nuclei were stained with DAPI, and 
arrowheads indicate centrosomes (C, E, F and G) or centrioles (D). Thin dotted lines in cell images in (C) and (D) indicate the 
contour of the cell.BMC Cell Biology 2009, 10:56 http://www.biomedcentral.com/1471-2121/10/56
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Figure 3 (see legend on next page)
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ARHGEF10 was also evident at least in G1/S and M phases
as demonstrated by using synchronized cell culture (Fig-
ures 1E and 1F). Virtually all centrosomes that we detected
by γ-tubulin staining were also positive for ARHGEF10.
Synchronization of these cells was confirmed by flow
cytometric analysis of DNA content (Figures 1E and 1F).
Therefore, ARHGEF10 may be involved in the control of
the cell division cycle.
To gain further insights into the function of ARHGEF10
during cell cycle progression, expression of endogenous
ARHGEF10 in HeLa cells was downregulated by two dif-
ferent sets of siRNAs. Decrease in the mRNA level was con-
firmed by RT-PCR analysis (Figure 2A), and the effect on
protein expression was assessed by the use of an epitope-
tagged ectopically expressed ARHGEF10 because we were
unable to detect endogenous ARHGEF10 by immunob-
lotting (Figure 2B). Following synchronization in M
phase by nocodazole treatment, aberrant multipolar spin-
dle formation was observed in 30~40% of ARHGEF10-
knockdown cells whereas more than 95% of control
siRNA-transfected cells showed normal bipolar spindles
under the same culture conditions (Figures 2C–2H). This
aberrant spindle formation was not merely due to noco-
dazole treatment because G2/M arrest of control siRNA-
transfected cells by nocodazole did not induce multipolar
spindles (Figures 2C and 2H), and we actually detected
multiple centrosomes in mitotic ARHGEF10-knockdown
cells without nocodazole treatment (data not shown).
ARHGEF10-specific siRNA indeed reduced the amount of
centrosome-localized ARHGEF10 (Figure 2C). Interest-
ingly, we reproducibly observed that two centrosomes
contain markedly reduced amounts of ARHGEF10
whereas the expression level of ARHGEF10 in the other
centrosome was decreased only partly. All mitotic spindle
poles in ARHGEF10-knockdown cells appeared to consist
of two centrioles as shown by immunostaining for the
centriole marker centrin (Figure 2D). Each centrosome
was indeed positive for PCM markers γ-tubulin, pericen-
trin and Aurora-A (Figures 2E–2G).
RhoA regulates mitotic spindle formation downstream of 
ARHGEF10
We next examined the involvement of Rho family
GTPases in ARHGEF10-dependent regulation of mitotic
spindle formation. Expression of the ARHGEF10 target
RhoA was reduced by specific siRNA sets (Figures 3A and
3B), and the effect on spindle pole formation was exam-
ined. Similarly to ARHGEF10 knockdown, multiple spin-
dle poles emerged (Figures 3C–3G). Each spindle pole in
fact harbored one centrosome consisting of two centrioles
and the PCM as shown by staining of marker proteins
(Figures 3C–3F). We also tried to see the effect of C3
exoenzyme, which specifically inactivates Rho proteins,
without success due to extensive cell death upon synchro-
nization of the cell (data not shown). Furthermore,
multipolar spindle formation induced by knockdown of
ARHGEF10 was rescued by ectopic expression of a consti-
tutively activated mutant of RhoA, but not Rac1 and
Cdc42, suggesting the involvement of RhoA downstream
of ARHGEF10 (Figure 3H). Rescue by constitutively acti-
vated RhoA was incomplete, but comparable to that by
the ARHGEF10 siRNA #1-resistant catalytic DH domain
of ARHGEF10 (ARHGEF10 [376–665]). The percentage of
cells containing multiple mitotic spindle poles shown in
Figure 3H was lower compared to that in Figure 2H
Role of RhoA downstream of ARHGEF10 Figure 3 (see previous page)
Role of RhoA downstream of ARHGEF10. (A) Effect of RhoA siRNAs on mRNA expression. Expression levels of endog-
enous RhoA and GAPDH (control) mRNAs in HeLa cells transfected with indicated siRNAs were measured by RT-PCR. (B) 
Effect of RhoA siRNA #3 on protein expression. Expression levels of HA × 3-tagged RhoA(wt) and α-tubulin (control) in HeLa 
cells transfected with indicated siRNAs were measured by immunoblotting. M, molecular weight markers. (C) Immunostaining 
of centrin and γ-tubulin in RhoA-knockdown cells. HeLa cells were transfected with RhoA siRNA #2 and synchronized in M 
phase with nocodazole. Indicated proteins were immunostained. High magnification images of boxed areas are shown in lower 
panels. Scale bar, 10 μm (upper panels) and 1 μm (lower panels). (D) Immunostaining of α-tubulin and γ-tubulin in RhoA-
knockdown cells. Indicated proteins in HeLa cells treated as in (C) were immunostained. Scale bar, 10 μm. (E) Immunostaining 
of α-tubulin and pericentrin in RhoA-knockdown cells. Indicated proteins in HeLa cells treated as in (C) were immunostained. 
Scale bar, 10 μm. (F) Immunostaining of α-tubulin and Aurora-A in RhoA-knockdown cells. Indicated proteins in HeLa cells 
treated as in (C) were immunostained. Scale bar, 10 μm. (G) Quantification of multipolar spindle formation in RhoA-knock-
down cells. HeLa cells were transfected with indicated siRNAs and synchronized in M phase with nocodazole. The percentage 
of cells containing multiple centrosomes are shown as the means ± S.E. for three independent experiments. *, P < 0.01. (H) 
Suppression of multipolar spindle formation in ARHGEF10-knockdown cells by RhoA. HeLa cells transfected with ARHGEF10 
siRNA #1 or control siRNA in combination with an expression plasmid for green fluorescent protein (GFP) (control), Myc-
tagged ARHGEF10(376–665) or HA × 3-tagged constitutively activated GTPases were synchronized in M phase with nocoda-
zole. The percentage of cells containing multiple centrosomes are shown as the means ± S.E. for three independent experi-
ments. *, P < 0.01. In (C) to (F), nuclei were stained with DAPI, and arrowheads indicate centrioles (C) or centrosomes (D, E 
and F). Thin dotted lines in cell images in (C) indicate the contour of the cell.BMC Cell Biology 2009, 10:56 http://www.biomedcentral.com/1471-2121/10/56
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Figure 4 (see legend on next page)
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because the amount of ARHGEF10 siRNA was reduced
when introduced with plasmid DNAs.
Multipolar spindle formation in ARHGEF10-knockdown 
cells is not ascribed to defects in cytokinesis
It is important to clarify whether multiple spindle forma-
tion in ARHGEF10-knockdown cells was due to defects in
cytokinesis. To this end, we utilized the ROCK pharmaco-
logical inhibitor Y-27632 as a control because ROCK is
intimately involved in the control of cytokinesis down-
stream of RhoA [5,6]. As a first step, mitotic spindle for-
mation in Y-27632-treated cells was examined under
conditions similar to those for siRNA-mediated knock-
down of ARHGEF10. HeLa cells were treated with Y-
27632 for 4 h prior to challenge with nocodazole, and
then subjected to synchronization in M phase. Y-27632
induced multiple mitotic spindle formation resembling
that observed in ARHGEF10- or RhoA-knockdown cells
(Figures 4A–4C), which may be ascribed to aberration in
cytokinesis. The percentage of multinucleated cells was
indeed increased upon Y-27632 treatment whereas virtu-
ally no increase was observed in ARHGEF10-knockdown
cells (Figure 4D). Fluorescence-activated cell sorter analy-
sis also support the notion that Y-27632 treatment, but
not ARHGEF10 knockdown, caused multinucleation pre-
sumably due to defects incytokinesis.
Nocodazole treatment increased 4N and 8N cell popula-
tions as expected (4N, 84.3 ± 0.809% [for three independ-
ent experiments]; 8N, 11.2 ± 0.866% [for three
independent experiments]). Transfection of control (4N,
79.4 ± 2.46% [for three independent experiments]; 8N,
11.1 ± 0.819% [for three independent experiments]) or
ARHGEF10-specific #1 (4N, 86.9 ± 1.88% [for three inde-
pendent experiments]; 8N, 7.27 ± 1.48% [for three inde-
pendent experiments]) siRNA did not significantly affect
the percentage of multi-nucleated (8N) cells. In contrast,
Y27632-treated cells showed higher percentage of multi-
nucleated (8N) cells (4N, 60.5 ± 5.55% [for three inde-
pendent experiments]; 8N, 24.9 ± 2.17% [for three inde-
pendent experiments]). (Figure 4E). Cleavage furrow
formation and cytokinesis were indeed observed in
ARHGEF10-knockdown tripolar cells(Figure 4F). In addi-
tion, RhoA was indeed accumulated in the midbody in
ARHGEF10-knockdown tripolar as well as control
cells(Figure 4F). Overall, these results suggest that occur-
rence of multiple centrosomes in ARHGEF10-knockdown
cells may not be due to abnormalities incytokinesis.
Instead, ARHGEF10 may have a crucial role in the regula-
tion of centrosome duplication considering that
ARHGEF10 is localized in centrosomes (Figures 1D–F). If
this is the case, aberrant centrosome duplication may
occur causing the formation of multiple spindle poles
when ARHGEF10 was knocked down.
The kinesin-like motor protein KIF3B may regulate 
ARHGEF10 as a binding partner
Through yeast two-hybrid screening for ARHGEF10-inter-
acting proteins, we isolated a clone encoding the C-termi-
nal portion (amino acids 480–747) of the kinesin-like
motor protein KIF3B. This portion does not overlap with
the microtubule-binding motor domain. The interaction
was confirmed by growth on the selection plate (Figure
5A) and the β-galactosidase assay (data not shown).
ARHGEF10 and KIF3B indeed co-localized in centro-
somes in HeLa cells (Figure 5B). The interaction between
ARHGEF10 and KIF3B was further confirmed by co-
immunoprecipitation from COS7 cells (Figure 5C).
Multinucleation in Y-27632-treated, but not ARHGEF10-knockdown, HeLa cells Figure 4 (see previous page)
Multinucleation in Y-27632-treated, but not ARHGEF10-knockdown, HeLa cells. (A) Immunostaining of centrin and 
γ-tubulin in Y-27632-treated cells. HeLa cells were treated with Y-27632 for 4 h and synchronized in M phase with nocodazole. 
Indicated proteins were immunostained. High magnification images of boxed areas are shown in lower panels. Scale bar, 10 μm 
(upper panels) and 1 μm (lower panels). (B) Immunostaining of α-tubulin and γ-tubulin in Y-27632-treated cells. Indicated pro-
teins in HeLa cells treated as in (A) were immunostained. Scale bar, 10 μm. (C) Quantification of multipolar spindle formation 
in Y-27632-treated cells. HeLa cells were treated with Y-27632 for 4 h and synchronized in M phase with nocodazole. The per-
centage of cells containing multiple centrosomes are shown as the means ± S.E. for three independent experiments. *, P < 0.01. 
(D) Increase of multinucleated cells upon Y-27632 treatment, but not ARHGEF10 knockdown. HeLa cells were transfected 
with ARHGEF10 siRNA #1 or treated with Y-27632 for 48 h and synchronized in M phase with nocodazole. Multinucleated 
cells as shown in the right panel were counted after 4 h-incubation without nocodazole. The percentage of multinucleated cells 
are shown as the means ± S.E. for three independent experiments. *, P < 0.01. Scale bar, 10 μm. (E) Flow cytometric analysis of 
DNA content in ARHGEF10-knockdown and Y-27632-treated HeLa cells. Representative fluorescence-activated cell sorter 
histograms and the percentage of cells contained in each peak are shown. (F) Cytokinesis of ARHGEF10-knockdown cells. 
HeLa cells were transfected with ARHGEF10 siRNA #1 or control siRNA in combination with an expression plasmid for HA × 
3-tagged RhoA(wt) and synchronized in M phase with nocodazole. Indicated proteins were immunostained after 3 h-incubation 
without nocodazole. Representative cells during cytokinesis are shown. Scale bar, 10 μm. In (A), (B), (D) and (F), nuclei were 
stained with DAPI, and arrowheads indicate centrioles (A) or centrosomes (B). Thin dotted lines in cell images in (A) and (F) 
indicate the contour of the cell.BMC Cell Biology 2009, 10:56 http://www.biomedcentral.com/1471-2121/10/56
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Interaction of KIF3B with ARHGEF10 Figure 5
Interaction of KIF3B with ARHGEF10. (A) Yeast two-hybrid interaction of KIF3B with ARHGEF10. cDNAs for 
ARHGEF10(1–1083) and KIF3B(480–747) were subcloned into yeast two-hybrid vectors pGBKT7 and pACT2, respectively, 
and two-hybrid interaction was assessed by growth on the selection plate (synthetic dropout medium-Trp/-Leu/-His/-Ade/+2.5 
mM 3-aminotriazole). pGBKT7-p53 and pACT2-T antigen were used as a positive control. (B) Co-localization of ARHGEF10 
and KIF3B in HeLa cells. HeLa cells were transfected with an expression plasmid for FLAG-tagged KIF3B, and indicated pro-
teins were immunostained. Arrowheads indicate centrosomes. Scale bar, 10 μm. Thin dotted lines indicate the contour of the 
cell. (C) Co-immunoprecipitation of KIF3B with ARHGEF10. Myc-tagged ARHGEF10 and FLAG-tagged KIF3B were expressed 
in COS7 cells as indicated, and association of these proteins was examined by co-immunoprecipitation. IP, immunoprecipita-
tion; IB, immunoblotting.
A
B
pGBKT7-ARHGEF10
pACT2
pGBKT7-ARHGEF10
pACT2-KIF3B
pGBKT7-p53
pACT2-T antigen
pGBKT7
pACT2-KIF3B
C
IP : Myc
Lysate
IB : Myc
IB : FLAG
IB : Myc
IB : FLAG
ARHGEF10 KIF3B ARHGEF10 ARHGEF10
++
KIF3B KIF3B
++ +- anti-Myc antibody
merge KIF3B ARHGEF10 DAPI
(1-1083)
(480-747) (480-747)
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Figure 6 (see legend on next page)
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Intriguingly, siRNA-mediated knockdown of KIF3B also
induced multiple spindle poles (Figure 6). Each spindle
pole indeed contains two centrioles and the PCM simi-
larly to ARHGEF10- or RhoA-knockdown cells (Figures
6C–6G). Thus, KIF3B may exert a regulatory role in
ARHGEF10-RhoA-mediated control of mitotic spindle
formation.
The supernumerary centrosome phenotype was also 
observed in S phase-arrested osteosarcoma U2OS cells 
when the expression of ARHGEF10, RhoA or KIF3B was 
reduced
The effect of knockdown of ARHGEF10, RhoA or KIF3B
was also examined in osteosarcoma U2OS cells arrested in
S phase by aphidicolin treatment (Figure 7). Supernumer-
ary centrosomes containing a pair of centrioles and the
PCM were observed in ARHGEF10-, RhoA- or KIF3B-
knockdown cells (Figure 7C–E).
However, when the expression of ARHGEF10, RhoA or
KIF3B was reduced, enhanced formation of multiple pro-
centrioles surrounding a parental centriole as reported in
Plk4-overexpressing cells [16] was not observed (data not
shown).
Discussion
In mitotic ARHGEF10-knockdown cells, we observed
multiple spindle poles, each of which contains two centri-
oles and the PCM. One possible mechanism for the for-
mation of such supernumerary centrosomes is aborted
cell division [1-3]. Aneuploid cells generated through
aberrant mitotic exit contain more than two centrosomes,
which may form multipolar spindles in next M phase. Ini-
tially, we thought that aberrant division of cells lacking
ARHGEF10 may frequently occur because RhoA is known
to be involved in many facets of mitotic and cytokinetic
control. However, the occurrence of multinucleated cells
was not affected by ARHGEF10 knockdown in contrast to
treatment with a ROCK inhibitor, which significantly
enhanced the formation of multinucleated cells (Figure
4). Furthermore, normal ingression of the cleavage furrow
was, in fact, detected in ARHGEF10-knockdown cells as
well (Figure 4F). Therefore, it is not feasible that
ARHGEF10 is responsible for RhoA activation in mitosis
and cytokinesis. Instead, ARHGEF10 may regulate RhoA
during interphase.
Deregulated centrosome duplication also leads to the for-
mation of multiple centrosomes and multipolar spindles
[1-3]. Thus, the multi-centrosome phenotype observed in
ARHGEF10-knockdown cells may be ascribed to disorder
in centrosome duplication. Localization of ARHGEF10 in
centrosomes strongly supports this notion. Centriole
duplication is initiated by the activation of cyclin-depend-
ent kinase 2 around the G1/S transition, concurrent with
DNA replication, and short daughter centrioles elongate
during S and G2 phases [17-19]. Following completion of
centriole elongation at the G2/M transition, centrosome
maturation and separation occur, with a pair of centrioles
in each centrosome. Centrosome duplication must occur
precisely once every cell cycle, being inextricably coupled
with other cell cycle-dependent events. To ensure this,
cells are afforded mechanisms (1) to limit centriole dupli-
cation to once in every cell division cycle and (2) to limit
the number of progenitor centrioles to one per pre-
existingcentriole.
Plenty of molecules that positively regulate centrosome
duplication, including Polo-like kinase-4 [16], cyclin-
dependent kinase 2 [17-19] and SPD-2 [20], have been
reported. The phenotype termed centriole overduplica-
tion (production of multiple daughter centrioles arranged
around each parental centriole) was observed when a pos-
itive regulator of centriole duplication, for instance Polo-
Multipolar spindle formation in KIF3B-knockdown HeLa cells Figure 6 (see previous page)
Multipolar spindle formation in KIF3B-knockdown HeLa cells. (A) Effect of KIF3B siRNAs on mRNA expression. 
Expression levels of endogenous KIF3B and GAPDH (control) mRNAs in HeLa cells transfected with indicated siRNAs were 
measured by RT-PCR. (B) Effect of KIF3B siRNA #2 on protein expression. Expression levels of FLAG-tagged KIF3B and α-
tubulin (control) in HeLa cells transfected with indicated siRNAs were measured by immunoblotting. M, molecular weight 
markers. (C) Immunostaining of centrin and γ-tubulin in KIF3B-knockdown cells. HeLa cells were transfected with KIF3B 
siRNA #2 and synchronized in M phase with nocodazole. Indicated proteins were immunostained. High magnification images of 
boxed areas are shown in lower panels. Scale bar, 10 μm (upper panels) and 1 μm (lower panels). (D) Immunostaining of α-
tubulin and γ-tubulin in KIF3B-knockdown cells. Indicated proteins in HeLa cells treated as in (C) were immunostained. Scale 
bar, 10 μm. (E) Immunostaining of α-tubulin and pericentrin in KIF3B-knockdown cells. Indicated proteins in HeLa cells treated 
as in (C) were immunostained. Scale bar, 10 μm. (F) Immunostaining of α-tubulin and Aurora-A in KIF3B-knockdown cells. 
Indicated proteins in HeLa cells treated as in (C) were immunostained. Scale bar, 10 μm. (G) Quantification of multipolar spin-
dle formation in KIF3B-knockdown cells. HeLa cells were transfected with indicated siRNAs and synchronized in M phase with 
nocodazole. The percentage of cells containing multiple centrosomes are shown as the means ± S.E. for three independent 
experiments. *, P < 0.01. In (C) to (F), nuclei were stained with DAPI, and arrowheads indicate centrioles (C) or centrosomes 
(D, E and F). Thin dotted lines in cell images in (C) indicate the contour of the cell.BMC Cell Biology 2009, 10:56 http://www.biomedcentral.com/1471-2121/10/56
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Figure 7 (see legend on next page)
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like kinase-4, is overexpressed [16] due to a disordered
mechanism to limit the number of progenitor centrioles.
The supernumerary centrosome formation described in
Figure 7 is distinct from this phenotype, and therefore, the
ARHGEF10-RhoA pathway may not be responsible for the
copy number control of procentrioles duplicated from a
single parental centriole.
One major mechanism to limit centriole duplication to
once in every cell division cycle involves a protein-digest-
ing enzyme termed separase, which is also responsible for
sister chromatid separation [21,22]. In the normal cell
division cycle, centrioles are prevented from duplicating
again during late S and G2 phases, being tightly connected
or engaged. At the end of mitosis, the engaged centriole
pair becomes dissociated, losing their strict orthogonal
orientation. This process, called disengagement, is trig-
gered by the action of separase, and is prerequisite for a
new round of centriole duplication [21,22]. Thus, intrin-
sic block to centriole reduplication throughout the cell
cycle and timely activation of separase represent a mecha-
nism to ensure that a new round of duplication can occur
only after passage through M phase. Although speculative,
disruption of the ARHGEF10-RhoA-dependent signaling
pathway by knocking down its component may permit an
excess cycle of centriole duplication if sustained engage-
ment of centrioles or suppression of separase activity dur-
ing late S and G2 phases requires this pathway. The
observation that only two among three centrosomes in
ARHGEF10-knockdown cells exhibit diminished
ARHGEF10 expression (Figure 2C) may be consistent
with the idea that only a centrosome that lacks
ARHGEF10 undergoes an excess duplication cycle before
mitosis.
Multiple mitotic spindles were also observed in cells defi-
cient in the Polo-like kinase-1 target Kizuna [23]. Unlike
Kizuna-depleted multipolar cells, however, we did not
detect fragmentation of the PCM in ARHGEF10-knock-
down cells, suggesting that the ARHGEF10-RhoA pathway
is not implicated in stabilization of the PCM in early
mitotic phase.
In this paper, we further identified the motor protein
KIF3B as a binding partner of ARHGEF10 (Figure 5).
KIF3B has been implicated in a variety of physiological
responses, including determination of left-right asymme-
try [24], axonal transport [25], assembly and maintenance
of the excitation-contraction-coupling membranes in
skeletal muscle [26], cytokinesis [27] and glucose trans-
port in adipocytes [28]. We observed multiple mitotic
spindle poles in KIF3B-knockdown cells (Figure 6),
resembling phenotypes observed following expression of
a dominant-negative mutant of KIF3B [29]. Considering
that ARHGEF10 associates with KIF3B in the centrosome,
KIF3B may regulate spindle pole formation through the
ARHGEF10-RhoA pathway. KIF3B knockdown may also
cause supernumerary centrosomes through cytokinesis
defects independently of ARHGEF10 because a dominant-
negative mutant of KIF3B caused chromosomal aneu-
ploidy [29]. The mechanisms may be more complicated
because it is reported that silencing of another motor pro-
tein KIFC5A causes centrosome amplification primarily
through reduplication and partly as a result of defects
incytokinesis [30].
Conclusion
ARHGEF10 is a RhoA GEF, which is localized in the cen-
trosome in both G1/S and M phases. ARHGEF10 regulates
mitotic spindle formation through the action of RhoA.
ARHGEF10-regulaed RhoA may be implicated in the con-
trol of centrosome duplication rather than cytokinesis.
The motor protein KIF3B is a binding partner of
ARHGEF10, a subset of which is co-localized with
ARHGEF10 in the centrosome.
Supernumerary centrosomes in aphidicolin-treated U2OS cells Figure 7 (see previous page)
Supernumerary centrosomes in aphidicolin-treated U2OS cells. (A) Effect of siRNAs for ARHGEF10, RhoA and 
KIF3B on mRNA expression. Expression levels of ARHGEF10, RhoA, KIF3B and GAPDH (control) mRNAs in U2OS cells 
transfected with indicated siRNAs were measured by RT-PCR. (B) Effect of siRNAs for ARHGEF10, RhoA and KIF3B on pro-
tein expression. Expression levels of Myc-tagged ARHGEF10, HA × 3-tagged RhoA(wt), FLAG-tagged KIF3B and α-tubulin 
(control) in U2OS cells transfected with indicated siRNAs were measured by immunoblotting. M, molecular weight markers. 
(C) Immunostaining of centrin and γ-tubulin in ARHGEF10-, RhoA- and KIF3B-knockdown cells. U2OS cells were transfected 
with ARHGEF10 siRNA #1, RhoA siRNA #3 or KIF3B siRNA #2 and synchronized in S phase with aphidicolin. Indicated pro-
teins were immunostained. High magnification images of boxed areas are shown in right panels. Scale bar, 2 μm (right panels) 
and 10 μm (other panels). (D) Immunostaining of pericentrin and γ-tubulin in ARHGEF10-, RhoA- and KIF3B-knockdown cells. 
Indicated proteins in U2OS cells treated as in (C) were immunostained. Scale bar, 10 μm. (E) Quantification of supernumerary 
centrosomes in ARHGEF10-, RhoA- and KIF3B-knockdown cells. U2OS cells were transfected with indicated siRNAs and syn-
chronized in S phase with aphidicolin. The percentage of cells containing multiple centrosomes are shown as the means ± S.E. 
for three independent experiments. *, P < 0.01. In (C) and (D), nuclei were stained with DAPI, and arrowheads indicate centri-
oles (C) or centrosomes (D). Thin dotted lines in cell images in (C) and (D) indicate the contour of the cell.Publish with BioMed Central    and   every 
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Thus, KIF3B may regulate ARHGEF10 upstream of RhoA,
being involved in the regulation of centrosome duplica-
tion.
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